Cargando…
Tumor microenvironment-driven non-cell-autonomous resistance to antineoplastic treatment
Drug resistance is of great concern in cancer treatment because most effective drugs are limited by the development of resistance following some periods of therapeutic administration. The tumor microenvironment (TME), which includes various types of cells and extracellular components, mediates tumor...
Autores principales: | Qu, Yidi, Dou, Bo, Tan, Horyue, Feng, Yibin, Wang, Ning, Wang, Di |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441162/ https://www.ncbi.nlm.nih.gov/pubmed/30927928 http://dx.doi.org/10.1186/s12943-019-0992-4 |
Ejemplares similares
-
Tumor Microenvironment and Immune Effects of Antineoplastic Therapy in Lymphoproliferative Syndromes
por: Álvaro, Tomás, et al.
Publicado: (2010) -
Resistance to antineoplastic drugs
por: Twentyman, Peter
Publicado: (1990) -
Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets
por: Zhong, Zhangfeng, et al.
Publicado: (2022) -
Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment
por: Wu, Peijie, et al.
Publicado: (2021) -
Prognostic value of immune-related genes in the tumor microenvironment of lung adenocarcinoma and lung squamous cell carcinoma
por: Qu, Yan, et al.
Publicado: (2020)